AAAAAA

   
Results: 1-25 | 26-50 | 51-59
Results: 26-50/59
A PHASE-II STUDY OF WEEKLY ORAL METHOTREXATE AND ZIDOVUDINE (AZT) IN ADVANCED ADENOCARCINOMA OF THE PANCREAS AND HEPATOCELLULAR-CARCINOMA
Authors: MILLER KD LOEHRER PJ GONIN R WEBER G ANSARI R PLETCHER W MCCLEAN J SPIRIDONIDIS CH MORTIMER J
Citation: Kd. Miller et al., A PHASE-II STUDY OF WEEKLY ORAL METHOTREXATE AND ZIDOVUDINE (AZT) IN ADVANCED ADENOCARCINOMA OF THE PANCREAS AND HEPATOCELLULAR-CARCINOMA, Investigational new drugs, 14(2), 1996, pp. 207-212
DISCORDANCE IN THE HISTOPATHOLOGIC DIAGNOSIS OF MELANOMA AND MELANOCYTIC NEVI BETWEEN EXPERT PATHOLOGISTS
Authors: FARMER ER GONIN R HANNA MP
Citation: Er. Farmer et al., DISCORDANCE IN THE HISTOPATHOLOGIC DIAGNOSIS OF MELANOMA AND MELANOCYTIC NEVI BETWEEN EXPERT PATHOLOGISTS, Human pathology, 27(6), 1996, pp. 528-531
USE OF SLIDING THIN-SLAB MAXIMUM INTENSITY PROJECTION IN THE DETECTION OF SIMULATED PULMONARY NODULES
Authors: COAKLEY FV COHEN MD JOHNSON MS HANNA MP GONIN R
Citation: Fv. Coakley et al., USE OF SLIDING THIN-SLAB MAXIMUM INTENSITY PROJECTION IN THE DETECTION OF SIMULATED PULMONARY NODULES, Radiology, 201, 1996, pp. 187-187
DETECTION OF PULMONARY METASTASES WITH SPIRAL CT - A CLINICAL-PATHOLOGICAL STUDY
Authors: COAKLEY FV COHEN MD WATERS DJ DAVIS MM HANNA MP GONIN R
Citation: Fv. Coakley et al., DETECTION OF PULMONARY METASTASES WITH SPIRAL CT - A CLINICAL-PATHOLOGICAL STUDY, Radiology, 201, 1996, pp. 188-188
IMMUNOHISTOLOGIC ASSESSMENT OF CD34 EXPRESSION IN BONE-MARROW SECTIONS, A POTENTIALLY USEFUL TECHNIQUE TO ASSESS MINIMAL RESIDUAL DISEASE (MRD) IN PEDIATRIC ACUTE LEUKEMIAS
Authors: WORAPONGPAIBOON S BUDKE H ORAZI A ROBERTSON P VIK T GONIN R NEIMAN R
Citation: S. Worapongpaiboon et al., IMMUNOHISTOLOGIC ASSESSMENT OF CD34 EXPRESSION IN BONE-MARROW SECTIONS, A POTENTIALLY USEFUL TECHNIQUE TO ASSESS MINIMAL RESIDUAL DISEASE (MRD) IN PEDIATRIC ACUTE LEUKEMIAS, Laboratory investigation, 74(1), 1996, pp. 891-891
DERMATOLOGY INDEX OF DISEASE SEVERITY
Authors: FAUST HB LEWIS CW CHUANG TY GONIN R MELFI C FARMER ER
Citation: Hb. Faust et al., DERMATOLOGY INDEX OF DISEASE SEVERITY, Journal of investigative dermatology, 106(4), 1996, pp. 520-520
ALLOGENEIC BONE-MARROW TRANSPLANTATION USING CD34 ENRICHED CELLS
Authors: CORNETTA K MILLS B HANNA M GHARPURE V HROMAS R ABONOUR R ROBERTSON M BROUN ER COX E WYMAN N MENKE C BAUTE J GONIN R KUNKEL L OLDHAM F SROUR EF
Citation: K. Cornetta et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION USING CD34 ENRICHED CELLS, Blood, 88(10), 1996, pp. 1920-1920
HISTOLOGIC EVALUATION OF PREAURICULAR AND POSTAURICULAR HUMAN SKIN AFTER HIGH-ENERGY, SHORT-PULSE CARBON-DIOXIDE LASER
Authors: COTTON J HOOD AF GONIN R BEESON WH HANKE CW
Citation: J. Cotton et al., HISTOLOGIC EVALUATION OF PREAURICULAR AND POSTAURICULAR HUMAN SKIN AFTER HIGH-ENERGY, SHORT-PULSE CARBON-DIOXIDE LASER, Archives of dermatology, 132(4), 1996, pp. 425-428
A PHASE-II TRIAL OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMAN INTERLEUKIN-2 IN PATIENTS WITH RELAPSED REFRACTORY THYMOMA
Authors: GORDON MS BATTIATO LA GONIN R HARRISONMANN BC LOEHRER PJ
Citation: Ms. Gordon et al., A PHASE-II TRIAL OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMAN INTERLEUKIN-2 IN PATIENTS WITH RELAPSED REFRACTORY THYMOMA, Journal of immunotherapy with emphasis on tumor immunology, 18(3), 1995, pp. 179-184
DISTINCT PATTERNS OF MINIMAL RESIDUAL DISEASE-ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: PICHERT G ROY DC GONIN R ALYEA EP BELANGER R GYGER M PERREAULT C BONNY Y LERRA I MURRAY C SOIFFER RJ RITZ J
Citation: G. Pichert et al., DISTINCT PATTERNS OF MINIMAL RESIDUAL DISEASE-ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 13(7), 1995, pp. 1704-1713
PHASE-III TRIAL OF THORACIC IRRADIATION WITH OR WITHOUT CISPLATIN FORLOCALLY ADVANCED UNRESECTABLE NON-SMALL-CELL LUNG-CANCER - A HOOSIER ONCOLOGY GROUP PROTOCOL
Authors: BLANKE C ANSARI R MANTRAVADI R GONIN R TOKARS R FISHER W PENNINGTON K OCONNOR T RYNARD S MILLER M EINHORN L
Citation: C. Blanke et al., PHASE-III TRIAL OF THORACIC IRRADIATION WITH OR WITHOUT CISPLATIN FORLOCALLY ADVANCED UNRESECTABLE NON-SMALL-CELL LUNG-CANCER - A HOOSIER ONCOLOGY GROUP PROTOCOL, Journal of clinical oncology, 13(6), 1995, pp. 1425-1429
LATE RELAPSE OF TESTICULAR CANCER
Authors: BANIEL J FOSTER RS GONIN R MESSEMER JE DONOHUE JP EINHORN LH
Citation: J. Baniel et al., LATE RELAPSE OF TESTICULAR CANCER, Journal of clinical oncology, 13(5), 1995, pp. 1170-1176
PHASE-II STUDY OF DAILY ORAL ETOPOSIDE PLUS IFOSFAMIDE PLUS CISPLATINFOR PREVIOUSLY TREATED RECURRENT SMALL-CELL LUNG-CANCER - A HOOSIER ONCOLOGY GROUP TRIAL
Authors: FAYLONA EA LOEHRER PJ ANSARI R SANDLER AB GONIN R EINHORN LH
Citation: Ea. Faylona et al., PHASE-II STUDY OF DAILY ORAL ETOPOSIDE PLUS IFOSFAMIDE PLUS CISPLATINFOR PREVIOUSLY TREATED RECURRENT SMALL-CELL LUNG-CANCER - A HOOSIER ONCOLOGY GROUP TRIAL, Journal of clinical oncology, 13(5), 1995, pp. 1209-1214
DEFINING NEW STANDARDS FOR ADJUVANT THERAPY OF TESTIS CANCER
Authors: NICHOLS CR GONIN R FOSTER R
Citation: Cr. Nichols et al., DEFINING NEW STANDARDS FOR ADJUVANT THERAPY OF TESTIS CANCER, Journal of clinical oncology, 13(11), 1995, pp. 2681-2683
CISPLATIN PLUS ETOPOSIDE WITH AND WITHOUT IFOSFAMIDE IN EXTENSIVE SMALL-CELL LUNG-CANCER - A HOOSIER ONCOLOGY GROUP-STUDY
Authors: LOEHRER PJ ANSARI R GONIN R MONACO F FISHER W SANDLER A EINHORN LH
Citation: Pj. Loehrer et al., CISPLATIN PLUS ETOPOSIDE WITH AND WITHOUT IFOSFAMIDE IN EXTENSIVE SMALL-CELL LUNG-CANCER - A HOOSIER ONCOLOGY GROUP-STUDY, Journal of clinical oncology, 13(10), 1995, pp. 2594-2599
PHASE-I STUDY OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITHAUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT
Authors: ELIAS AD AYASH LJ WHEELER C SCHWARTZ G TEPLER I GONIN R MCCAULEY M MAZANET R SCHNIPPER L FREI E ANTMAN KH
Citation: Ad. Elias et al., PHASE-I STUDY OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITHAUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT, Bone marrow transplantation, 15(3), 1995, pp. 373-379
INTERFERON-INDUCIBLE PROTEIN-10 AND MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA INHIBIT GROWTH-FACTOR STIMULATION OF RAF-1 KINASE-ACTIVITY AND PROTEIN-SYNTHESIS IN A HUMAN GROWTH FACTOR-DEPENDENT HEMATOPOIETIC-CELL LINE
Authors: ARONICA SM MANTEL C GONIN R MARSHALL MS SARRIS A COOPER S HAGUE N ZHANG XF BROXMEYER HE
Citation: Sm. Aronica et al., INTERFERON-INDUCIBLE PROTEIN-10 AND MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA INHIBIT GROWTH-FACTOR STIMULATION OF RAF-1 KINASE-ACTIVITY AND PROTEIN-SYNTHESIS IN A HUMAN GROWTH FACTOR-DEPENDENT HEMATOPOIETIC-CELL LINE, The Journal of biological chemistry, 270(37), 1995, pp. 21998-22007
VARIATION IN MEASURED KT V IN CONSECUTIVE DIALYSIS TREATMENTS/
Authors: MARSH DE CORYELL P GONIN R HASBARGEN JA
Citation: De. Marsh et al., VARIATION IN MEASURED KT V IN CONSECUTIVE DIALYSIS TREATMENTS/, Journal of the American Society of Nephrology, 5(3), 1994, pp. 522-522
PHASE-II TRIAL OF VINBLASTINE, IFOSFAMIDE, AND GALLIUM COMBINATION CHEMOTHERAPY IN METASTATIC UROTHELIAL CARCINOMA
Authors: EINHORN LH ROTH BJ ANSARI R DREICER R GONIN R LOEHRER PJ
Citation: Lh. Einhorn et al., PHASE-II TRIAL OF VINBLASTINE, IFOSFAMIDE, AND GALLIUM COMBINATION CHEMOTHERAPY IN METASTATIC UROTHELIAL CARCINOMA, Journal of clinical oncology, 12(11), 1994, pp. 2271-2276
DOUBLE DOSE-INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS MARROW AND PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR METASTATIC BREAST-CANCER - A FEASIBILITY STUDY
Authors: AYASH LJ ELIAS A WHEELER C REICH E SCHWARTZ G MAZANEF R TEPLER I WARREN D LYNCH C GONIN R SCHNIPPER L FREI E ANTMAN K
Citation: Lj. Ayash et al., DOUBLE DOSE-INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS MARROW AND PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR METASTATIC BREAST-CANCER - A FEASIBILITY STUDY, Journal of clinical oncology, 12(1), 1994, pp. 37-44
PHASE-IV TRIAL OF DAILY ORAL ETOPOSIDE IN THE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMA
Authors: LICHT JD MAZANET R LOEHRER PJ GONIN R ANTMAN KH
Citation: Jd. Licht et al., PHASE-IV TRIAL OF DAILY ORAL ETOPOSIDE IN THE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMA, Cancer chemotherapy and pharmacology, 34(1), 1994, pp. 79-80
NEOADJUVANT TREATMENT OF STAGE IIIA NONSMALL CELL LUNG-CANCER - LONG-TERM RESULTS
Authors: ELIAS AD SKARIN AT GONIN R OLIYNYK P STOMPER PC OHARA C SOCINSKI MA SHELDON T MAGGS P FREI E
Citation: Ad. Elias et al., NEOADJUVANT TREATMENT OF STAGE IIIA NONSMALL CELL LUNG-CANCER - LONG-TERM RESULTS, American journal of clinical oncology, 17(1), 1994, pp. 26-36
PAIN AND ITS TREATMENT IN OUTPATIENTS WITH METASTATIC CANCER
Authors: CLEELAND CS GONIN R HATFIELD AK EDMONSON JH BLUM RH STEWART JA PANDYA KJ
Citation: Cs. Cleeland et al., PAIN AND ITS TREATMENT IN OUTPATIENTS WITH METASTATIC CANCER, The New England journal of medicine, 330(9), 1994, pp. 592-596
COMPARISON OF ANTIBODY CONCENTRATIONS AND PROTECTIVE ACTIVITY OF RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN AND CONVENTIONAL IMMUNE GLOBULIN
Authors: SIBER GR LEOMBRUNO D LESZCZYNSKI J MCIVER J BODKIN D GONIN R THOMPSON CM WALSH EE PIEDRA PA HEMMING VG PRINCE GA
Citation: Gr. Siber et al., COMPARISON OF ANTIBODY CONCENTRATIONS AND PROTECTIVE ACTIVITY OF RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN AND CONVENTIONAL IMMUNE GLOBULIN, The Journal of infectious diseases, 169(6), 1994, pp. 1368-1373
EFFECT OF LOW-DOSE INTERLEUKIN-2 ON DISEASE RELAPSE AFTER T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: SOIFFER RJ MURRAY C GONIN R RITZ J
Citation: Rj. Soiffer et al., EFFECT OF LOW-DOSE INTERLEUKIN-2 ON DISEASE RELAPSE AFTER T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(3), 1994, pp. 964-971
Risultati: 1-25 | 26-50 | 51-59